Skip to main content Skip to footer content
goto homepage NIHR Birmingham Biomedical Research Centre
Click to search
  • Staff resources
  • Contact us
Menu
  • Home
  • About us
    • Our partnerships and infrastructure
    • Our impact
      • Case studies
    • Meet the team
    • Delivering equity, equality, diversity and inclusion in research
      • NIHR Birmingham BRC-CRF Joint Equity, Equality, Diversity and Inclusion Strategy 2022-2027
  • Our research
    • Our research projects
    • Inflammatory arthritis
    • Cancer inflammation
      • Cancer inflammation team
    • Infection and acute care
      • Infection and acute care team
    • Inflammatory liver disease
      • Inflammatory liver disease team
    • Women’s metabolic health
      • Women’s metabolic health team
    • Oral, intestinal and systemic health
      • Oral, intestinal and systemic health team
    • Sarcopenia and multimorbidity
    • Thrombo-inflammation
    • Data, diagnostics and decision tools
      • Data, diagnostics and decision tools team
    • Next generation therapies
      • Next generation therapies team
    • Patient-reported outcomes
      • Patient-reported outcomes team
  • News and events
  • Patients and the public
    • What research do we do?
    • Ways you can get involved in research
    • Why should I get involved in research?
    • How do I get involved?
    • Meet the PPIE team
    • How are the public involved in the BRC?
    • Help and support for you
    • Our strategy
      • NIHR Birmingham BRC-CRF Joint Patient and Public Involvement and Engagement Strategy 2022-2027
  • Industry and partners
  • Staff resources
    • Acknowledging the Birmingham BRC
    • Our branding
    • Involving patients and the public in your research
    • Communicating your research
    • Joint BRC and CTU New Business Proposal Process
    • NIHR Open Access policy
  • Training
  • Research inclusion
  • Home
  • About us
    • Our partnerships and infrastructure
    • Our impact
      • Case studies
    • Meet the team
    • Delivering equity, equality, diversity and inclusion in research
      • NIHR Birmingham BRC-CRF Joint Equity, Equality, Diversity and Inclusion Strategy 2022-2027
  • Our research
    • Our research projects
    • Inflammatory arthritis
    • Cancer inflammation
      • Cancer inflammation team
    • Infection and acute care
      • Infection and acute care team
    • Inflammatory liver disease
      • Inflammatory liver disease team
    • Women’s metabolic health
      • Women’s metabolic health team
    • Oral, intestinal and systemic health
      • Oral, intestinal and systemic health team
    • Sarcopenia and multimorbidity
    • Thrombo-inflammation
    • Data, diagnostics and decision tools
      • Data, diagnostics and decision tools team
    • Next generation therapies
      • Next generation therapies team
    • Patient-reported outcomes
      • Patient-reported outcomes team
  • News and events
  • Patients and the public
    • What research do we do?
    • Ways you can get involved in research
    • Why should I get involved in research?
    • How do I get involved?
    • Meet the PPIE team
    • How are the public involved in the BRC?
    • Help and support for you
    • Our strategy
      • NIHR Birmingham BRC-CRF Joint Patient and Public Involvement and Engagement Strategy 2022-2027
  • Industry and partners
  • Staff resources
    • Acknowledging the Birmingham BRC
    • Our branding
    • Involving patients and the public in your research
    • Communicating your research
    • Joint BRC and CTU New Business Proposal Process
    • NIHR Open Access policy
  • Training
  • Research inclusion
Share your feedback

Home » News » Obesity-related fat cell signals shown to drive muscle loss in older adults

Obesity-related fat cell signals shown to drive muscle loss in older adults

27 February, 2026

Person with obesity sitting on a sofa

Research theme

Sarcopenia and multimorbidity

People involved

Professor Simon Jones

Sarcopenia and Multimorbidity Theme Lead

Researchers at the University of Birmingham have identified a new mechanism by which obesity may contribute to muscle loss in older adults, offering important insights into the condition known as sarcopenic obesity.

The study, published in the Journal of Cachexia, Sarcopenia and Muscle and delivered through the National Institute for Health and Care Research (NIHR) Birmingham Biomedical Research Centre (BRC) shows for the first time that extracellular vesicles — tiny particles released by fat tissue — can directly trigger muscle atrophy in human cells, providing new insight into how ageing and obesity interact to influence muscle loss.

Sarcopenic obesity, where excess body fat coexists with reduced muscle mass and strength, is an increasingly common condition in ageing populations and is associated with frailty, reduced mobility, and poorer overall health outcomes. It is estimated to affect around 11% of the population. 

In the study, researchers found that extracellular vesicles released from obese adipose (fat) tissue — but not lean tissue — caused significant thinning of muscle fibres derived from older adults. This effect was driven by specific molecular cargo carried within the vesicles, particularly miR-150-5p, a microRNA which influences gene expression pathways involved in muscle maintenance.

Crucially, the researchers found that muscle cells derived from younger adults were resilient to these effects. Exposure to obese adipose tissue and its extracellular vesicles did not trigger muscle thinning in younger muscle cells, highlighting an age-dependent vulnerability.

It isn’t just having more fat tissue that matters. Obesity changes how fat tissue behaves and how it communicates with muscle.

Dr Joshua Price, first author and postdoctoral researcher

Speaking about the findings of the study, Dr Joshua Price, first author and BRC-funded Postdoctoral Researcher within the Sarcopenia and Multimorbidity research theme, said: “It isn’t just having more fat tissue that matters. Obesity changes how fat tissue behaves and how it communicates with muscle. Ageing muscle is far more vulnerable to these altered signals, which helps explain why muscle loss accelerates with obesity later in life.”

The study identified this microRNA as a potential future therapeutic target, as inhibiting it could partly alleviate the muscle-wasting effect. The cumulative findings show that younger muscle has a protective resilience, whereas older muscle is made more vulnerable to the inflammatory and metabolic signals associated with obesity.

Through this research, we’ve identified a key molecular pathway by which obesity can accelerate muscle loss in older adults…This reinforces the importance of maintaining a healthy weight and muscle health as we age.

Professor Simon Jones, Professor in Musculoskeletal Ageing

Professor Simon Jones, senior author of the study, Professor in Musculoskeletal Ageing at the University of Birmingham and lead for the NIHR Birmingham BRC’s Sarcopenia and Multimorbidity research theme, said: “Through this research, we’ve identified a key molecular pathway by which obesity can accelerate muscle loss in older adults. Importantly, we found that younger muscle appears resilient to these harmful signals, whereas ageing muscle becomes more vulnerable. This reinforces the importance of maintaining a healthy weight and muscle health as we age.”

“Our findings also open two potential therapeutic avenues: either blocking or modifying the harmful extracellular vesicles released from obese tissue, or developing strategies to make older muscle more resilient, mimicking the protective effects seen in younger muscle.”

Share
X feed Share on X
linkedin feed Share on linkedin
Print this page
Email

You may also like

News

6 May 2026

Common inflammatory genes link pancreatic cancer with…

Sarcopenia and multimorbidity
News

5 May 2026

Obesity leaves a lasting memory in immune…

Sarcopenia and multimorbidity
News

17 Apr 2026

Where lived experience meets science: Highlights from…

Sarcopenia and multimorbidity
Patient and public involvement
View more news

Contact us

NIHR Birmingham Biomedical Research Centre
Institute of Translational Medicine

Birmingham
B15 2TH

birminghamBRC@uhb.nhs.uk

Quick links

  • About us
  • Events
  • Our partners
  • Privacy
  • Cookies
  • Accessibility

Follow us on

  • twitter feed BirminghamBRC
  • linkedin feed LinkedIn

Subscribe to our newsletter

Sign up to our newsletter to stay up to date with the latest news and events from the NIHR Birmingham BRC

Subscribe now

The NIHR Birmingham Biomedical Research Centre (BRC) is part of the NIHR and hosted by University Hospitals Birmingham NHS Foundation Trust (UHBFT) in partnership with the University of Birmingham (UoB).

Copyright © Designed by:
NHS Midlands and Lancashire Commissioning Support Unit
NHS Arden and Greater East Midlands Commissioning Support Unit

Back to top

Cookies on the NIHR website. We’ve put some small files called cookies on your device to make our site work. We’d also like to use analytics cookies. These send information about how our site is used to a service called Google Analytics. We use this information to improve our site. Let us know if this is OK. We’ll use a cookie to save your choice. You can read more about our cookies before you choose. Alternatively, you can change your preferences.